fnhlid1
Trade name: BiovaxID
Biologicalexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2000 (NCT00091676)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fnhlid1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00091676 | Phase 3 | Jan 1, 2000 | Biovest International, University of Pennsylvania |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biovest International | For profit | 1 | 1 | 1 | 2000 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2000 |
2 organizations
Page 1 / 1